A CALCIUM CARBONATE, ACS CEP of the European Pharmacopoeia monograph is often referred to as a CALCIUM CARBONATE, ACS Certificate of Suitability (COS). The purpose of a CALCIUM CARBONATE, ACS CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CALCIUM CARBONATE, ACS EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CALCIUM CARBONATE, ACS to their clients by showing that a CALCIUM CARBONATE, ACS CEP has been issued for it. The manufacturer submits a CALCIUM CARBONATE, ACS CEP (COS) as part of the market authorization procedure, and it takes on the role of a CALCIUM CARBONATE, ACS CEP holder for the record. Additionally, the data presented in the CALCIUM CARBONATE, ACS CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CALCIUM CARBONATE, ACS DMF.
A CALCIUM CARBONATE, ACS CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CALCIUM CARBONATE, ACS CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CALCIUM CARBONATE, ACS suppliers with CEP (COS) on PharmaCompass.